The last three consecutive epidermal growth factor-like structures of human thrombomodulin comprise the minimum functional domain for protein C-activating cofactor activity and anticoagulant activity - PubMed (original) (raw)
. 1989 Jun 25;264(18):10351-3.
Affiliations
- PMID: 2543666
Free article
The last three consecutive epidermal growth factor-like structures of human thrombomodulin comprise the minimum functional domain for protein C-activating cofactor activity and anticoagulant activity
M Zushi et al. J Biol Chem. 1989.
Free article
Abstract
We have identified a minimum functional domain of human thrombomodulin for anticoagulant activity using deletion analysis. Four mutants were constructed by site-directed deletion mutagenesis to delete one or more epidermal growth factor (EGF)-like structures from the domain of human thrombomodulin containing six repeated EGF-like structures. These deletion mutants were expressed transiently in COS-1 cells, and their protein C-activating cofactor activities in the culture medium were examined. One mutant protein, E456, which contains the fourth, fifth, and sixth EGF-like structures expresses apparent cofactor activity. However, neither E456-N24 (24 NH2-terminal-residue deletion) nor E456-C16 (16 COOH-terminal-residue deletion) have cofactor activity. E456 was partially purified and its anticoagulant effects on plasma clotting time and platelet aggregation examined. E456 expressed almost the same anticoagulant activities as D123 which contains six consecutive EGF-like structures of thrombomodulin. It was concluded that E456 is the minimum functional domain for both protein C-activating cofactor activity and anticoagulant activity.
Similar articles
- Aspartic acid 349 in the fourth epidermal growth factor-like structure of human thrombomodulin plays a role in its Ca(2+)-mediated binding to protein C.
Zushi M, Gomi K, Honda G, Kondo S, Yamamoto S, Hayashi T, Suzuki K. Zushi M, et al. J Biol Chem. 1991 Oct 25;266(30):19886-9. J Biol Chem. 1991. PMID: 1657904 - Further localization of binding sites for thrombin and protein C in human thrombomodulin.
Hayashi T, Zushi M, Yamamoto S, Suzuki K. Hayashi T, et al. J Biol Chem. 1990 Nov 25;265(33):20156-9. J Biol Chem. 1990. PMID: 2173698 - Thrombomodulin structure and function.
Sadler JE. Sadler JE. Thromb Haemost. 1997 Jul;78(1):392-5. Thromb Haemost. 1997. PMID: 9198185 Review. - Gene structure of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for thrombin-catalyzed activation of protein C.
Suzuki K. Suzuki K. Nihon Ketsueki Gakkai Zasshi. 1988 Dec;51(8):1655-64. Nihon Ketsueki Gakkai Zasshi. 1988. PMID: 2854698 Review. No abstract available.
Cited by
- Identification of the predominant glycosaminoglycan-attachment site in soluble recombinant human thrombomodulin: potential regulation of functionality by glycosyltransferase competition for serine474.
Gerlitz B, Hassell T, Vlahos CJ, Parkinson JF, Bang NU, Grinnell BW. Gerlitz B, et al. Biochem J. 1993 Oct 1;295 ( Pt 1)(Pt 1):131-40. doi: 10.1042/bj2950131. Biochem J. 1993. PMID: 8216207 Free PMC article. - Thrombomodulin distribution during murine development.
Ford VA, Wilkinson JE, Kennel SJ. Ford VA, et al. Rouxs Arch Dev Biol. 1993 Aug;202(6):364-370. doi: 10.1007/BF00188735. Rouxs Arch Dev Biol. 1993. PMID: 28306049 - End-point immobilization of recombinant thrombomodulin via sortase-mediated ligation.
Jiang R, Weingart J, Zhang H, Ma Y, Sun XL. Jiang R, et al. Bioconjug Chem. 2012 Mar 21;23(3):643-9. doi: 10.1021/bc200661w. Epub 2012 Mar 8. Bioconjug Chem. 2012. PMID: 22372933 Free PMC article. - Successful treatment of disseminated intravascular coagulation by recombinant human soluble thrombomodulin in patients with acute myeloid leukemia.
Ookura M, Hosono N, Tasaki T, Oiwa K, Fujita K, Ito K, Lee S, Matsuda Y, Morita M, Tai K, Negoro E, Kishi S, Iwasaki H, Ueda T, Yamauchi T. Ookura M, et al. Medicine (Baltimore). 2018 Nov;97(44):e12981. doi: 10.1097/MD.0000000000012981. Medicine (Baltimore). 2018. PMID: 30383650 Free PMC article. - The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism.
Abeyama K, Stern DM, Ito Y, Kawahara K, Yoshimoto Y, Tanaka M, Uchimura T, Ida N, Yamazaki Y, Yamada S, Yamamoto Y, Yamamoto H, Iino S, Taniguchi N, Maruyama I. Abeyama K, et al. J Clin Invest. 2005 May;115(5):1267-74. doi: 10.1172/JCI22782. Epub 2005 Apr 14. J Clin Invest. 2005. PMID: 15841214 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources